Our science: First, faster, and for patients
At AbbVie, our R&D teams are chasing bold goals. Investing in promising scientific discoveries and cutting-edge technology to develop innovative medicines–and bring them to patients faster.
Our research & development approach
Science and innovation are the lifeblood of our company. From drug discovery to clinical trials to regulatory approval, we're pursuing new ways to address patients' most challenging health issues.
Since our launch in 2013, we've invested more than $73 billion in R&D. This enables us to discover and deliver innovative medicines and products to help solve serious health issues, enhance people's lives today, and address tomorrow's medical challenges.
We focus on core areas where our proven expertise and bold thinking have the greatest potential to solve unmet needs. These areas are oncology, immunology, neuroscience, eye care, and medical aesthetics.
To develop innovative medicines, you need innovative people. Our teams collaborate across disciplines to connect people and ideas, fueling a culture of curiosity and problem-solving.
Our R&D work fuels a dynamic and diverse pipeline that continues to advance and deliver medicines and solutions for patients.
The need to do more for patients motivates our R&D work. By investing in boundary-pushing approaches, we aim to advance programmes with a stronger probability of success and move assets forward faster.
Core focus areas:
A community of global thinkers
To develop innovative medicines, you need innovative people — lots of them. We have robust teams of biologists, chemists, clinicians, mathematicians, data scientists, engineers, and others working side by side with colleagues in regulatory affairs, patient safety, manufacturing and more. Our teams collaborate across disciplines to connect people and ideas, fueling a culture of curiosity and problem-solving.
Get Involved
Interested in joining our team of innovative scientists and researchers?
UK-ABBV-260024 | February 2026
-
Leave the UK site?
You are now leaving the AbbVie UK corporate website and are being re-directed to an AbbVie UK corporate social media channel. This may contain links to external platforms outside of the control of AbbVie and for which AbbVie is not responsible.
-
Leave the UK site?
You are now leaving the AbbVie UK corporate website and are being re-directed to an AbbVie UK corporate social media channel. This may contain links to external platforms outside of the control of AbbVie and for which AbbVie is not responsible.
-
You are about to be redirected to an AbbVie site.
If you are a UK patient or healthcare professional contacting us with a Medical Information request, you can contact us via [email protected] or 01628 561092
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2026 AbbVie Inc. North Chicago, Illinois, U.S.A.
UK-ABBV-260001 | February 2026
